Skip to main content
Log in

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

  • Original Articles
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

Weight loss is the main symptom of so-called tumor cachexia. The pathogenetic mechanisms underlying cachexia are poorly understood; however, it appears that enhanced formation of cytokines such as interferon-γ and tumor necrosis factor-α are involved. In 94 patients suffering from hematological neoplasias we compared body weight changes with serum neopterin, tryptophan, and kynurenine. Biochemical changes, the formation of neopterin, the degradation of tryptophan are closely related to interferon-γ activity. The majority of our patients had increased neopterin and decreased tryptophan concentrations. Weight loss was seen particularly in patients with higher neopterin and lower tryptophan values. An association between higher neopterin levels and greater weight loss was apparent at study entry and during the follow-up of patients. Our data support the concept that weight loss is closely linked to endogenous interferon-γ activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NHL:

non-Hodgkin's lymphoma

HD:

Hodgkin's disease

MM:

multiple myeloma

MGUS:

monoclonal gammopathy of unknown significance

IFN-γ:

interferon-γ

TNF-α:

tumor necrosis factor-α

References

  1. Balkwill F, Burke F, Talbot D, Taverniere J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 11:1229–1232

    Google Scholar 

  2. Bonadonna G, Santoro A, Viviani S, Valagussa P (1988) Treatment strategies for Hodgkin's disease. Sem Hematol 25:51–57

    Google Scholar 

  3. Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM (1989) Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2. Cancer Res 49:4941–4944

    Google Scholar 

  4. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report on the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860–1861

    CAS  PubMed  Google Scholar 

  5. Denz HA, Fuchs D, Grünewald K, Huber H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H (1990) Urinary neopterin as a prognostic factor in haematological neoplasias. Pteridines 1:167–170

    Google Scholar 

  6. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H (1990) Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 44:186–189

    Google Scholar 

  7. Denz H, Landmann R, Orth B, Wachter H, Fuchs D (1992) Associations between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Haematol 48:245–249

    Google Scholar 

  8. DeWyss WD, Begg C, Lavin PT, Band PR, Bennet JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight-loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–501

    Google Scholar 

  9. Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854

    CAS  PubMed  Google Scholar 

  10. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H (1988) Neopterin as a marker for activated cell-mediated immunity — application in HIV infection. Immunol Today 9:150–155

    Google Scholar 

  11. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner E, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS 3:873–876

    Google Scholar 

  12. Fuchs D, Dotevall L, Hagberg L, Werner ER, Wachter H (1991) Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis. Immunol Infect Dis 1:271–274

    Google Scholar 

  13. Herrmann F, Cannistra SA, Griffin JD (1986) T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro. J Immunol 136:2856–2861

    Google Scholar 

  14. Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73: 517–526

    Google Scholar 

  15. Matthys P, Dukmans R, Proost P, Van Damme J, Heremans H, Sobis H, Billiau A (1991) Severe cachexia in mice inoculated with interferon-gamma producing tumor cells. Int J Cancer 49:77–82

    Google Scholar 

  16. Metcalf D (1989) Haematopoietic growth factors 1. Lancet 1:825–827

    Google Scholar 

  17. Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:450–456

    Google Scholar 

  18. Morrison SD (1989) Cancer cachexia. In: Liotta LA (ed) Influence of tumor development on the host. Series Kaiser HE: Cancer growth and progression (3). Kluwer Academic Publishers, Dordrecht, pp 176–213

    Google Scholar 

  19. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry S (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211–1227

    Google Scholar 

  20. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER (1989) Neopterin as marker of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27:81–141

    Google Scholar 

  21. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G (1992) Neopterin: biochemistry-methods-clinical Application. de Gruyter, Berlin

    Google Scholar 

  22. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H (1987) Human macrophages degrade tryptophan upon induction by interferon gamma. Life Sci 41:273–280

    Google Scholar 

  23. Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1987) Simultaneous determination of neopterin and creatinine in serum with solid phase extraction and on-line elution liquid chromatography. Clin Chem 33:2028–2033

    Google Scholar 

  24. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1989) Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069

    Google Scholar 

  25. Wright SC, Jewett A, Misuyasu R, Bonavida B (1988) Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 141:99–104

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denz, H., Orth, B., Weiss, G. et al. Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Clin Investig 71, 37–41 (1993). https://doi.org/10.1007/BF00210961

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00210961

Key words

Navigation